Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;4(6 Pt 1):101766.
doi: 10.1016/j.jacadv.2025.101766. Epub 2025 May 12.

The Diagnostic and Prognostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy

Affiliations

The Diagnostic and Prognostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy

Leonardo Calò et al. JACC Adv. 2025 Jun.

Abstract

Background: Electrocardiographic findings in arrhythmogenic left ventricular cardiomyopathy (ALVC) have been limited to small studies.

Objectives: The authors aimed to analyze the electrocardiogram (ECG) characteristics of ALVC, to correlate ECG with cardiac magnetic resonance and genetic data, and to evaluate its prognostic value.

Methods: We reviewed data of 125 consecutive patients with ALVC (81.5% desmoplakin pathogenic/likely pathogenic variants). The composite endpoint of major arrhythmic events (MAEs) included sudden cardiac death, aborted sudden cardiac death, and appropriate implantable cardioverter-defibrillator shock. Predictors of MAE were evaluated with logistic regression.

Results: ALVC showed distinct ECG signs, including left posterior fascicular block (LPFB) (13.6%), pathological Q waves (26.4%), R/S ratio in V1 ≥0.5 (26.4%), and SV1 + RV6 ≤12 mm and RI + RII ≤8 mm (44%). Fifteen (12%) patients had a normal ECG. MAE occurred in 35 patients (28%). In multivariable analysis, LPFB (OR: 4.7; 95% CI: 1.2-18.3), syncope (OR: 84.95; 95% CI: 14-496), transmural late gadolinium enhancement (OR: 9.95; 95% CI: 2.3-36), and right ventricular ejection fraction (OR: 0.92; 95% CI: 0.87-0.97) were the independent predictors of MAE. The model including these 4 variables achieved a remarkable predictive capability (area under the curve: 0.9). In the primary prevention scenario, with Cox regression, LPFB (HR: 3.98; 95% CI: 1.3-12.0), syncope (HR: 19.13; 95% CI: 5.8-63.0), and transmural late gadolinium enhancement (HR: 10.57; 95% CI: 2.9-38.0) were independent predictors of MAE.

Conclusions: In ALVC, ECG is a valuable diagnostic tool and may have a relevant prognostic role, since LFPB is a strong and independent predictor of MAE.

Keywords: ECG; arrhythmias; arrhythmogenic cardiomyopathy; cardiomyopathy; desmoplakin; desmosome; magnetic resonance imaging; prognosis; sudden cardiac death.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures The work reported in this publication was funded by the Italian Ministry of Health, RC-2022-2773270 project to Dr Biagini and by FSC 2014 to 2020, grant id. T3-AN-04 “GENERA” to Dr Novelli. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Electrocardiographic Findings in Patients With Arrhythmogenic Left Ventricular Cardiomyopathy (A) Electrocardiogram of patient #56 (19-year-old man, pathogenic variant in desmoglein-2 c.271G>T, p.Gly91Ter) shows left posterior fascicular block, a fragmented QRS in V1 to V3 and T-wave inversion in V3 to V5. (B) Electrocardiogram of patient #83 (71-year-old man, likely pathogenic variant in desmoglein-2 p.Val295Serfs∗6) displays global low QRS voltage, anterior T-wave inversion, and R/S ratio ≥0.5 in V1 (red box). (C) Electrocardiogram of patient #19 (35-year-old man with pathogenic variant in desmoplakin c.5210delG p.Gly1737AspfsTer16) displays low QRS voltage in limb leads and pathological inferior Q waves (blue boxes). (D) Patient #86 (14-year-old man, pathogenic variant in plakophilin-2, c.1378+1G>C), had an aborted sudden cardiac death at presentation; his electrocardiogram shows left posterior fascicular block and T-wave inversion in V1 to V3. A sum of the R-wave in I to II ≤8 mm and SV1 + RV6 ≤12 mm, a R/S ratio ≥0.5 in V1 are also present. All the electrocardiograms presented were performed at 25 mm/s with 1 mm/mV.
Figure 2
Figure 2
Electrocardiographic Changes During Follow-Up (A and B) Patient #38 is a man with a pathogenic variant in desmoplakin (deletion of the entire desmoplakin gene, 6p25.1-p24.3). Electrocardiogram at age 28 shows T-wave inversion in lateral leads. After 6 years, electrocardiogram shows the appearance of left posterior fascicular block (violet box) and T-wave inversion in leads V2 to V3 (asterisks). (C and D) Electrocardiograms of patient #45 (48-year-old man, likely pathogenic variant in desmoplakin c.860A>G, p.Asn287Ser) display the presence of low QRS voltages in lateral leads and the appearance over time of left posterior fascicular block and pathological Q waves in inferior leads (violet box). (E and F) Electrocardiogram of patient #108 (18-year-old man, pathogenic variant in desmoplakin c.2821C>T, P.Arg941∗) shows low QRS voltages in the lateral leads. After 4 years, the electrocardiogram shows the appearance of T-wave inversion in inferior leads and in V3 to V6 (asterisks), polymorphic premature ventricular beats.
Central Illustration
Central Illustration
The Diagnostic and Prognostic Role of the Electrocardiogram in Arrhythmogenic Left Ventricular Cardiomyopathy ALVC = arrhythmogenic left ventricular cardiomyopathy; DSP = desmoplakin; ECG = electrocardiogram; LGE = late gadolinium enhancement; LPFB = left posterior fascicular block; LQRSV = low QRS voltages; MAE = major arrhythmic events; RVEF = right ventricular ejection fraction; TWI = T-wave inversion.

References

    1. Norman M., Simpson M., Mogensen J., et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation. 2005;112:636–642. doi: 10.1161/CIRCULATIONAHA.104.532234. - DOI - PubMed
    1. Bauce B., Basso C., Rampazzo A., et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J. 2005;26:1666–1675. doi: 10.1093/eurheartj/ehi341. - DOI - PubMed
    1. Sen-Chowdhry S., Syrris P., Ward D., Asimaki A., Sevdalis E., McKenna W.J. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 2007;115:1710–1720. doi: 10.1161/CIRCULATIONAHA.106.660241. - DOI - PubMed
    1. Sen-Chowdhry S., Syrris P., Prasad S.K., et al. Left-dominant arrhythmogenic cardiomyopathy: an underrecognized clinical entity. J Am Coll Cardiol. 2008;52:2175–2187. doi: 10.1016/j.jacc.2008.09.019. - DOI - PubMed
    1. Cipriani A., Bauce B., De Lazzari M., et al. Arrhythmogenic right ventricular cardiomyopathy: characterization of left ventricular phenotype and differential diagnosis with dilated cardiomyopathy. J Am Heart Assoc. 2020;9 doi: 10.1161/JAHA.119.014628. - DOI - PMC - PubMed